Mutya Harsch

Insider Reports History

Location
Rehovot, Israel
Signature
/s/ Mutya Harsch
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mutya Harsch:

Company Role Class Num Shares Value Price $ Report Date Ownership
VYNE Therapeutics Inc. CHIEF LEGAL OFFICER AND GC Common Stock 125,905 $73,037 $0.5801 31 Dec 2025 Direct
VYNE Therapeutics Inc. CHIEF LEGAL OFFICER AND GC Stock Option (right to buy) 230,000 21 Jan 2025 Direct
Satsuma Pharmaceuticals, Inc. Director Stock Option (right to buy) 0 08 Jun 2023 Direct

Insider Reports Filed by Mutya Harsch

Symbol Company Period Transactions Value $ Form Type Role Filing Time
VYNE VYNE Therapeutics Inc. 31 Dec 2025 1 -$2,076 4 CHIEF LEGAL OFFICER AND GC 05 Jan 2026, 08:30
VYNE VYNE Therapeutics Inc. 30 Sep 2025 1 -$1,200 4 CHIEF LEGAL OFFICER AND GC 02 Oct 2025, 17:05
VYNE VYNE Therapeutics Inc. 30 Jun 2025 1 -$5,909 4 CHIEF LEGAL OFFICER AND GC 02 Jul 2025, 16:30
VYNE VYNE Therapeutics Inc. 02 Jun 2025 1 +$927 4 CHIEF LEGAL OFFICER AND GC 03 Jun 2025, 16:15
VYNE VYNE Therapeutics Inc. 31 Mar 2025 1 -$13,948 4 CHIEF LEGAL OFFICER AND GC 02 Apr 2025, 16:15
VYNE VYNE Therapeutics Inc. 21 Jan 2025 1 $0 4 CHIEF LEGAL OFFICER AND GC 23 Jan 2025, 16:15
VYNE VYNE Therapeutics Inc. 31 Dec 2024 1 -$15,735 4 CHIEF LEGAL OFFICER AND GC 02 Jan 2025, 17:45
VYNE VYNE Therapeutics Inc. 30 Sep 2024 1 -$197 4 CHIEF LEGAL OFFICER AND GC 02 Oct 2024, 16:15
VYNE VYNE Therapeutics Inc. 01 Jul 2024 1 -$275 4 CHIEF LEGAL OFFICER AND GC 03 Jul 2024, 16:15
VYNE VYNE Therapeutics Inc. 01 Apr 2024 1 -$496 4 CHIEF LEGAL OFFICER AND GC 03 Apr 2024, 17:04
VYNE VYNE Therapeutics Inc. 01 Jan 2024 3 -$367 4 Chief Legal Officer and GC 03 Jan 2024, 17:20
VYNE VYNE Therapeutics Inc. 13 Dec 2023 2 $0 4 Chief Legal Officer and GC 15 Dec 2023, 17:09
VYNE VYNE Therapeutics Inc. 02 Oct 2023 1 -$4,420 4 Chief Legal Officer and GC 04 Oct 2023, 16:21
VYNE VYNE Therapeutics Inc. 30 Jun 2023 1 -$644 4 Chief Legal Officer and GC 05 Jul 2023, 16:32
/report/000089924323014864-harsch-mutya-2023-06-08 Satsuma Pharmaceuticals, Inc. 08 Jun 2023 2 $0 4 Director 08 Jun 2023, 16:17
VYNE VYNE Therapeutics Inc. 31 May 2023 1 +$12,664 4 Chief Legal Officer and GC 02 Jun 2023, 16:34
VYNE VYNE Therapeutics Inc. 31 Mar 2023 1 -$1,472 4 Chief Legal Officer and GC 04 Apr 2023, 17:03
VYNE VYNE Therapeutics Inc. 20 Mar 2023 1 +$25,000 4 Chief Legal Officer and GC 22 Mar 2023, 16:01
VYNE VYNE Therapeutics Inc. 31 Dec 2022 1 -$272 4 Chief Legal Officer and GC 04 Jan 2023, 16:12
VYNE VYNE Therapeutics Inc. 30 Sep 2022 1 -$404 4 Chief Legal Officer and GC 04 Oct 2022, 17:04
VYNE VYNE Therapeutics Inc. 30 Jun 2022 1 -$705 4 Chief Legal Officer and GC 05 Jul 2022, 17:00
/report/000156761922012471-harsch-mutya-2022-06-03 Satsuma Pharmaceuticals, Inc. 03 Jun 2022 1 $0 4 Director 07 Jun 2022, 17:36
VYNE VYNE Therapeutics Inc. 31 Mar 2022 1 -$2,360 4 Chief Legal Officer and GC 04 Apr 2022, 17:09
VYNE VYNE Therapeutics Inc. 17 Mar 2022 2 $0 4 Chief Legal Officer and GC 18 Mar 2022, 17:09
VYNE VYNE Therapeutics Inc. 31 Dec 2021 1 -$1,514 4 Chief Legal Officer and GC 04 Jan 2022, 15:40
/report/000156761921018223-harsch-mutya-2021-10-11 Satsuma Pharmaceuticals, Inc. 11 Oct 2021 1 $0 4 Director 12 Oct 2021, 17:17
/report/000156761921018222-harsch-mutya-2021-10-11 Satsuma Pharmaceuticals, Inc. 11 Oct 2021 0 $0 3 Director 12 Oct 2021, 17:15
VYNE VYNE Therapeutics Inc. 30 Sep 2021 1 -$2,063 4 Chief Legal Officer and GC 01 Oct 2021, 17:11
VYNE VYNE Therapeutics Inc. 02 Sep 2021 2 $0 4 Chief Legal Officer and GC 03 Sep 2021, 17:34
VYNE VYNE Therapeutics Inc. 30 Jun 2021 1 -$12,464 4 Chief Legal Officer and GC 02 Jul 2021, 16:36